Daniel Georgiev co-founded XENO Cell Innovations in 2016 to make diagnostic and bioengineering technologies that compute. XENO BIOLOGIC devices supplant large instrumentation and lab personnel by gathering and processing information in the same sample volume. Daniel received a PhD in Systems and control theory and a MSc in Applied mathematics from the University of Michigan. Following a postdoc in the Klavins Lab, University of Washington, and a brief entrepreneurial sidestep, he founded the first regional synthetic biology laboratory that spawned the 2015 iGEM runner-up team. His research focuses on defining system principles in specific bioengineering contexts.
Daniel GeorgievNoeleen O'Hara